Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
PBYI
PBYI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PBYI News
Puma Biotechnology Grants Stock Awards to New Employees
Feb 04 2026
Newsfilter
EU and India Reach Landmark Trade Agreement
Jan 27 2026
CNBC
Puma Biotechnology Grants 10,500 Restricted Stock Units to New Employees
Jan 07 2026
Businesswire
Puma Biotechnology Added to Nasdaq Biotechnology Index, Enhancing Visibility
Dec 22 2025
Businesswire
Puma Biotechnology Grants 3,500 Restricted Stock Units to New Employee
Dec 02 2025
Businesswire
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Superior Choice?
Nov 27 2025
NASDAQ.COM
Daily Upgrade Report for Validea Kenneth Fisher Strategy - November 11, 2025
Nov 11 2025
NASDAQ.COM
Puma Biotech (PBYI) Exceeds Expectations with Q3 Earnings and Revenue
Nov 07 2025
NASDAQ.COM
Puma Biotechnology Inc. Reports Decline in Q3 Profit, Surpassing Expectations
Nov 06 2025
NASDAQ.COM
CRISPR Therapeutics (CRSP) Rises 8.7%: Could This Signal More Growth Ahead?
Oct 09 2025
NASDAQ.COM
Puma Biotechnology Announces Inducement Awards in Compliance with Nasdaq Listing Rule 5635(c)(4)
Oct 02 2025
Newsfilter
PBYI Rises 30% Over Three Months: What’s the Best Strategy for Investors?
Sep 15 2025
NASDAQ.COM
Puma Biotechnology Announces Inducement Grants in Compliance with Nasdaq Listing Rule 5635(c)(4)
Sep 04 2025
Newsfilter
Validea Joel Greenblatt Strategy Daily Upgrade Report - 8/14/2025
Aug 14 2025
NASDAQ.COM
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Aug 08 2025
Newsfilter
Puma Biotechnology, Inc. (PBYI) Q2 2025 Earnings Call Transcript
Aug 08 2025
Newsfilter
Show More News
